Ellen Cusano, MD

Coagulation fellow @HemUcsd | Hematology grad @UCalgaryMed 2023 | Hemostasis nerd ♥️🩸

[UCSD Hematology/Oncology Fellowship @HemUcsd]

Congratulations to Hemostasis and Thrombosis fellow, @CusanoEllen, on her oral presentation: Clinical and Economic Outcome Analysis of First-Line Immunosuppression in Acquired Hemophilia A!

[UCSD Hematology/Oncology Fellowship @HemUcsd]

It was an absolutely incredible weekend at #ASH24! Congratulations to all of the UCSD faculty and fellow presenters, including Dr. Von Drygalski, @TroSekayan, @parthivshethmd, and @CusanoEllen. We are so proud of your work! See the thread below for more details! 🩸

[Ellen Cusano, MD @CusanoEllen]

@BrownJHM @NicoGagelmann Systemic mastocytosis - avapritinib

[Ellen Cusano, MD @CusanoEllen]

@dinnerwithjulie The TBCC even had some fun with them at the beginning of the pandemic!

[Ellen Cusano, MD @CusanoEllen]

Choosing a career where every day is #RareDiseaseDay 🩸 >>>

Excited to take care of, and do research for, patients with rare bleeding and clotting disorders for the foreseeable future!

[Ellen Cusano, MD @CusanoEllen]

Fortuitous timing - I presented the phase 3 XTEND-1 trial (https://t.co/mxbSthew4y) for journal club today.

Very exciting for patients with hemophilia - a once weekly FVIII prophylaxis option!

Will patiently await Health Canada approval …

[Sanofi US @SanofiUS]

#WeNeverSettle in our efforts to address the unmet needs of people with #RareBloodDisorders. Today’s @US_FDA approval marks an important step in transforming treatment for people living with #hemophilia A.

Read more about this new option: https://t.co/tpbaEUlY6B

[Ellen Cusano, MD @CusanoEllen]

The best way to kick off #ASH22!
Met amazing colleagues and learned from the experts - highly recommend to any trainees interested in classical hematology!

[Hemostasis and Thrombosis Research Society @HTRStoday]

Our Trainee Workshop last week in New Orleans was a great success! Residents and fellows - it's not too late to apply for the next workshop this March in Orlando. The deadline is Friday, December 16. APPLY NOW! https://t.co/5Lk6IGP51X @HTRSFellows #hematology #HemeTwitter

[Arnav Agarwal @ArnavAgarwalMD]

Systematic reviewers, guideline developers & clinicians face a trade-off when considering relying on pre-print evidence.

How do pre-prints fare relative to their later publications?

Brilliant work by @DenaZera, published in @BMJMedicine, addresses this.

https://t.co/QQ4cJZCqY8

[Dena Zeraatkar @DenaZera]

The preprint to end all….trial publications?! 📄Pleased to see this published. @BMJMedicine @TylerSC10 @CusanoEllen @radagabriel @Elena_Kum @jessbartoszko @chiragjp

[Tyler Pitre, MD PhD🇨🇦 @TylerSC10]

Our new paper in @CMAJ! A network meta-analysis investigating antivirals in non-severe COVID-19 infection!💊
https://t.co/IJ9NZjlHCW

Paxlovid >molnupiravir>remdesivir. @DenaZera @CusanoEllen @FaranKhalidPK @McMasterIntMed @HEI_mcmaster @MacDeptMed @MacMedWRC #research
#COVID19

[Ellen Cusano, MD @CusanoEllen]

Room 10/10 and presentation 10/10!

Thank you for sharing your knowledge and passion with us at @AHCDC1. Excited to work on improving care for women with bleeding disorders as a hematology community!🩸

[Shematologist, MD @acweyand]

Presenting to 🇨🇦 @AHCDC1
today on Issues of Health Inequity Pertaining to Women with Bleeding Disorders.

@ratemyskyperoom I have an hour, what should I change?

[Ellen Cusano, MD @CusanoEllen]

@Sueypig Pure strategy ;)

[Ellen Cusano, MD @CusanoEllen]

My first go at wordle. Had to see what all the fuss (and angry tweets today) were all about. 🤷🏼‍♀️

Wordle 265 5/6

🟨⬜️🟨⬜️🟩
⬜️🟩🟩🟩🟩
⬜️🟩🟩🟩🟩
🟨⬜️🟨🟨⬜️
🟩🟩🟩🟩🟩

[Ellen Cusano, MD @CusanoEllen]

Absolutely NAILED this one 🤣

[Dr. Glaucomflecken @DGlaucomflecken]

How to speak internal medicine

[Ellen Cusano, MD @CusanoEllen]

https://t.co/kQshiwR5ZF

[Ellen Cusano, MD @CusanoEllen]

In patients with severe or critical covid-19:

Tocilizumab + steroids probably reduces mortality; sarilumab + steroids could reduce mortality. Tocilizumab and sarilumab, without steroids, might not be beneficial | @BMJMedicine

[Tyler Pitre, MD PhD🇨🇦 @TylerSC10]

IL-6 inhibitors for COVID-19! Another excellent contribution by @DenaZera et al! Not every day you get a paper that informs WHO guidelines on drug treatments for COVID-19 https://t.co/n9aCSaCZ6n

[Ellen Cusano, MD @CusanoEllen]

@CSIMSCMI @iBookCC online chapters, podcast, tweetorials - they are all fantastic and very relevant to IM, not just critical care!

[Ellen Cusano, MD @CusanoEllen]

Currently at the point in this pandemic where my bank account has enough data points to create “insights” on my pizza consumption 💁🏼‍♀️

@dominos #pieceofthepierewards

[Ellen Cusano, MD @CusanoEllen]

Did the EXACT same thing with the program director of the program I desperately wanted to subspecialty match into. Months later I’m thrilled to be in the program and have such an amazing leader/culture. But the memory still gives me palpitations!! 🤦🏼‍♀️

[Hannah Abrams, MD @HannahRAbrams]

Sign of a kind culture: When you accidentally call the WRONG critical care attending at 3:50AM to talk through a problem, and they listen for 5 min before offering a suggestion/some reassurance & politely explaining you meant to call the OI. 🤦🏻‍♀️

[Ellen Cusano, MD @CusanoEllen]

Spotify wrap-up but make it nerdy.

IYKYK.